$NB
NIOCORP DEVELOPMENTS LTD Stock $nb

$nb Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000153949723001028 Filed on May 30, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.330M	$1.562M	$324.0K
YoY Change	423.6%	382.1%	-20.98%
% of Gross Profit
Research & Development	$1.330M	$1.410M	$845.0K
YoY Change	-1.63%	66.86%	181.67%
% of Gross Profit
Depreciation & Amortization	$0.00	$1.000K	$1.000K
YoY Change	-100.0%	0.0%
% of Gross Profit
Operating Expenses	$3.940M	$29.19M	$1.386M
YoY Change	85.32%	2006.2%	63.06%
Operating Profit
YoY Change
Interest Expense	-$750.0K	$142.0K	-$430.0K
YoY Change	31.81%	-133.02%	126.32%
% of Operating Profit
Other Income/Expense, Net			$0.00
YoY Change			-100.0%
Pretax Income	-$4.690M	-$29.62M	-$1.816M
YoY Change	74.03%	1531.11%	79.8%
Income Tax	-$120.0K	-$186.0K
% Of Pretax Income
Net Earnings	-$4.430M	-$29.34M	-$1.816M
YoY Change	64.38%	1515.8%	79.8%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.15	-$1.03	-$6.833K
COMMON SHARES
Basic Shares Outstanding	30.40M shares	282.5M shares	26.58M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.340M	$7.145M	$3.464M
YoY Change	-55.68%	106.26%	-59.86%
Cash & Equivalents	$2.341M	$7.145M	$3.464M
Short-Term Investments
Other Short-Term Assets	$1.390M	$96.00K	$541.0K
YoY Change	245.77%	-82.26%	2605.0%
Inventory
Prepaid Expenses	$1.385M
Receivables
Other Receivables
Total Short-Term Assets	$3.726M	$7.241M	$4.005M
YoY Change	-34.42%	80.8%	-53.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$839.0K	$17.17M	$17.05M
YoY Change	-1.29%	0.75%	57.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$10.00K	$7.000K	$10.00K
YoY Change	0.0%	-30.0%	-50.0%
Other Assets	$40.00K	$35.00K	$35.00K
YoY Change	14.29%	0.0%	-12.5%
Total Long-Term Assets	$17.20M	$17.22M	$17.09M
YoY Change	0.76%	0.73%	57.23%
TOTAL ASSETS
Total Short-Term Assets	$3.726M	$7.241M	$4.005M
Total Long-Term Assets	$17.20M	$17.22M	$17.09M
Total Assets	$20.93M	$24.46M	$21.10M
YoY Change	-8.02%	15.93%	8.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.491M	$2.055M	$59.00K
YoY Change	2935.65%	3383.05%	-68.95%
Accrued Expenses	$252.0K	$149.0K	$740.0K
YoY Change	0.0%	-79.86%	89.74%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$1.289M	$2.000M
YoY Change	-100.0%	-35.55%	-47.64%
Long-Term Debt Due	$0.00	$0.00	$2.585M
YoY Change	-100.0%	-100.0%	91.48%
Total Short-Term Liabilities	$3.562M	$4.678M	$5.384M
YoY Change	-3.6%	-13.11%	-6.2%
LONG-TERM LIABILITIES
Long-Term Debt	$10.56M	$12.26M	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$4.989M	$5.303M	$44.00K
YoY Change	21591.3%	11952.27%	-66.15%
Total Long-Term Liabilities	$4.989M	$5.303M	$44.00K
YoY Change	21591.3%	11952.27%	-99.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.562M	$4.678M	$5.384M
Total Long-Term Liabilities	$4.989M	$5.303M	$44.00K
Total Liabilities	$29.80M	$34.74M	$5.428M
YoY Change	701.43%	539.92%	-60.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$150.5M	-$146.0M	-$106.3M
YoY Change	38.05%	37.38%
Common Stock	$140.4M	$134.4M
YoY Change	8.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.97M	-$12.51M	$15.67M
YoY Change
Total Liabilities & Shareholders Equity	$20.93M	$24.46M	$21.10M
YoY Change	-8.02%	15.93%	8.07%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$4.430M	-$29.34M	-$1.816M
YoY Change	64.38%	1515.8%	79.8%
Depreciation, Depletion And Amortization	$0.00	$1.000K	$1.000K
YoY Change	-100.0%	0.0%
Cash From Operating Activities	-$5.830M	-$7.341M	-$1.456M
YoY Change	235.83%	404.19%	-22.96%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.020M	14.17M	10.00K
YoY Change	-72.02%	141580.0%	-99.9%
NET CHANGE
Cash From Operating Activities	-5.830M	-7.341M	-1.456M
Cash From Investing Activities	0.000	0.000	0.000
Cash From Financing Activities	1.020M	14.17M	10.00K
Net Change In Cash	-4.810M	6.827M	-1.446M
YoY Change	-351.83%	-572.13%	-117.09%
FREE CASH FLOW
Cash From Operating Activities	-$5.830M	-$7.341M	-$1.456M
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$5.830M	-$7.341M	-$1.456M
YoY Change	235.83%	404.19%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001512228
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
CY2022Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2022Q2	niobf	Earnout Liability At Fair Value EarnoutLiabilityAtFairValue		usd
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount		usd
	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2022	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2022Q1	niobf	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability		usd
CY2022Q1	niobf	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability		usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount		usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest		usd
CY2022Q1	us-gaap	Oci Equity Method Investment Before Tax Noncontrolling Interest OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest		usd
	us-gaap	Oci Equity Method Investment Before Tax Noncontrolling Interest OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest		usd
	niobf	Assumption Of Private And Public Warrants AssumptionOfPrivateAndPublicWarrants		usd
	niobf	Assumption Of Earnout Liability AssumptionOfEarnoutLiability		usd
	niobf	Change In Fair Value Of Earnout Share Liability ChangeInFairValueOfEarnoutShareLiability		usd
	niobf	Fair Value Of Commitment Shares Issued FairValueOfCommitmentSharesIssued		usd
	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings		usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
	niobf	Stock Issued During Period Value Business Combination StockIssuedDuringPeriodValueBusinessCombination		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q1	niobf	Stock Issued During Period Value Business Combination StockIssuedDuringPeriodValueBusinessCombination		usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	-1422000	usd
CY2022Q3	niobf	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest1 IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1	-3877000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	37000	usd
	niobf	Net Loss NetLoss	8080000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-72000	usd
	niobf	Foreign Currency Transaction Gain Loss Before Tax1 ForeignCurrencyTransactionGainLossBeforeTax1	-148000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8080000	usd
	us-gaap	Capital Expenditure Discontinued Operations CapitalExpenditureDiscontinuedOperations	109005	usd
CY2022Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent		usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Fair Value Disclosure AccountsPayableAndAccruedLiabilitiesFairValueDisclosure		usd
	niobf	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised		shares
	niobf	Class Of Warrant Or Right Exercise Price Exercised ClassOfWarrantOrRightExercisePriceExercised
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55710
	dei	Entity Registrant Name EntityRegistrantName	NioCorp Developments Ltd.
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1262185
	dei	Entity Address Address Line1 EntityAddressAddressLine1	7000 South Yosemite Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 115
	dei	Entity Address City Or Town EntityAddressCityOrTown	Centennial
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80112
	dei	City Area Code CityAreaCode	720
	dei	Local Phone Number LocalPhoneNumber	334-7066
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30396120	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7145000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5280000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	96000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	402000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	7241000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	5682000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	35000	usd
CY2022Q2	us-gaap	Other Assets OtherAssets	35000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	7000	usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	10000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	248000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	94000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	840000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	850000	usd
CY2023Q1	us-gaap	Capitalized Costs Mineral Interests In Unproved Properties CapitalizedCostsMineralInterestsInUnprovedProperties	16085000	usd
CY2022Q2	us-gaap	Capitalized Costs Mineral Interests In Unproved Properties CapitalizedCostsMineralInterestsInUnprovedProperties	16085000	usd
CY2023Q1	us-gaap	Assets Assets	24456000	usd
CY2022Q2	us-gaap	Assets Assets	22756000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3319000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	817000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1289000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2000000	usd
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2169000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	70000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	82000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4678000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5068000	usd
CY2023Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	12263000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5303000	usd
CY2023Q1	niobf	Earnout Liability At Fair Value EarnoutLiabilityAtFairValue	12314000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	177000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	34735000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	5091000	usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	2233000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30081655	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27667060	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	134445000	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	129055000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-146046000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-110397000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-911000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-993000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12512000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17665000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24456000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22756000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1405000	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	308000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1989000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1859000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	157000	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	16000	usd
	us-gaap	Professional Fees ProfessionalFees	583000	usd
	us-gaap	Professional Fees ProfessionalFees	530000	usd
CY2023Q1	niobf	Exploration Expenditures ExplorationExpenditures	1410000	usd
CY2022Q1	niobf	Exploration Expenditures ExplorationExpenditures	845000	usd
	niobf	Exploration Expenditures ExplorationExpenditures	4015000	usd
	niobf	Exploration Expenditures ExplorationExpenditures	1957000	usd
CY2023Q1	us-gaap	Other General Expense OtherGeneralExpense	26220000	usd
CY2022Q1	us-gaap	Other General Expense OtherGeneralExpense	217000	usd
	us-gaap	Other General Expense OtherGeneralExpense	26888000	usd
	us-gaap	Other General Expense OtherGeneralExpense	1324000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	29192000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1386000	usd
	us-gaap	Operating Expenses OperatingExpenses	33475000	usd
	us-gaap	Operating Expenses OperatingExpenses	5670000	usd
CY2023Q1	niobf	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	881000	usd
	niobf	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	881000	usd
CY2023Q1	niobf	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-784000	usd
	niobf	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-868000	usd
CY2023Q1	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	300000	usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	1922000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-83000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	66000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-192000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-98000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	142000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	679000	usd
	us-gaap	Interest Expense InterestExpense	362000	usd
	us-gaap	Interest Expense InterestExpense	2306000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	13000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	1000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	1000	usd
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	2000	usd
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	6000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-29621000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-35927000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8080000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-186000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-186000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-29435000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2000000	usd
	us-gaap	Profit Loss ProfitLoss	-35741000	usd
	us-gaap	Profit Loss ProfitLoss	-8080000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-92000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-92000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-29343000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-35649000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8080000	usd
CY2023Q1	niobf	Profit Loss1 ProfitLoss1	-29435000	usd
CY2022Q1	niobf	Profit Loss1 ProfitLoss1	-2000000	usd
	niobf	Profit Loss1 ProfitLoss1	-35741000	usd
	niobf	Profit Loss1 ProfitLoss1	-8080000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-112000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	38000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-82000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-72000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	29323000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2038000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	35659000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8008000	usd
CY2023Q1	us-gaap	Oci Equity Method Investment Before Tax Noncontrolling Interest OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest	92000	usd
	us-gaap	Oci Equity Method Investment Before Tax Noncontrolling Interest OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest	92000	usd
CY2023Q1	us-gaap	Oci Equity Method Investment Before Tax Parent OciEquityMethodInvestmentBeforeTaxParent	29231000	usd
CY2022Q1	us-gaap	Oci Equity Method Investment Before Tax Parent OciEquityMethodInvestmentBeforeTaxParent	2038000	usd
	us-gaap	Oci Equity Method Investment Before Tax Parent OciEquityMethodInvestmentBeforeTaxParent	35567000	usd
	us-gaap	Oci Equity Method Investment Before Tax Parent OciEquityMethodInvestmentBeforeTaxParent	8008000	usd
CY2023Q1	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	1.00
CY2022Q1	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.08
	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	1.26
	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.31
CY2023Q1	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	28546379	shares
CY2022Q1	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	26576440	shares
	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	28128731	shares
	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	26172981	shares
	us-gaap	Profit Loss ProfitLoss	-35741000	usd
	us-gaap	Profit Loss ProfitLoss	-8080000	usd
	niobf	Assumption Of Private And Public Warrants AssumptionOfPrivateAndPublicWarrants	3848000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	868000	usd
	niobf	Assumption Of Earnout Liability AssumptionOfEarnoutLiability	13195000	usd
	niobf	Change In Fair Value Of Earnout Share Liability ChangeInFairValueOfEarnoutShareLiability	-881000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1788000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1568000	usd
	niobf	Fair Value Of Commitment Shares Issued FairValueOfCommitmentSharesIssued	650000	usd
	us-gaap	Accretion Expense AccretionExpense	215000	usd
	us-gaap	Accretion Expense AccretionExpense	2149000	usd
	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	-1422000	usd
	niobf	Foreign Currency Transaction Gain Loss Before Tax1 ForeignCurrencyTransactionGainLossBeforeTax1	-200000	usd
	niobf	Foreign Currency Transaction Gain Loss Before Tax1 ForeignCurrencyTransactionGainLossBeforeTax1	-148000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-6000	usd
	us-gaap	Depreciation Depreciation	2000	usd
	us-gaap	Depreciation Depreciation	2000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	13000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-12000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-5000	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-14457000	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-4212000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-304000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	516000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2688000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	314000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11465000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4414000	usd
	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	16000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	21000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	21000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	973000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	21000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	515000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	14857000	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	1130000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1841000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	318000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13621000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	655000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-312000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-78000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1865000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3853000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5280000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7317000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7145000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3464000	usd
	us-gaap	Interest Paid Net InterestPaidNet	239000	usd
	us-gaap	Interest Paid Net InterestPaidNet	40000	usd
	niobf	Conversions Of Debt For Common Shares ConversionsOfDebtForCommonShares	1950000	usd
	niobf	Conversions Of Debt For Common Shares ConversionsOfDebtForCommonShares	6622000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13213000	usd
	niobf	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	543000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	430000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	6622000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1568000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	72000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8080000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	14368000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17665000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	usd
	niobf	Stock Issued During Period Value Fair Value Of Financing Warrants Issued StockIssuedDuringPeriodValueFairValueOfFinancingWarrantsIssued	3337000	usd
	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-2325000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	650000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	1950000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-21000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1788000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	82000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-35649000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-12512000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	14296000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	2100000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	37000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2000000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	14368000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13269000	usd
CY2023Q1	niobf	Fair Value Of Financing Warrants Issued FairValueOfFinancingWarrantsIssued	3337000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-2325000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	650000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1788000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	112000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-29343000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-12512000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80F_eus-gaap--NatureOfOperations_zLuV7ggfS7Kb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82B_z0MnOinxLWs5">DESCRIPTION OF BUSINESS</span></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp Developments Ltd. (“we,” “us,” “our,” “NioCorp” or the “Company”) was incorporated on February 27, 1987, under the laws of the Province of British Columbia and currently operates in <span id="xdx_909_eus-gaap--NumberOfReportableSegments_dxL_uN_c20220701__20230331_zociJmdozle9" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0673">one</span></span> reportable operating segment consisting of exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property (the “Elk Creek Project”) located in southeastern Nebraska.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As further discussed in Notes 5, 8, and 9, on March 17, 2023 (the “Closing Date”), the Company closed the GXII Transaction (as defined below) with GX Acquisition Corp. II (“GXII”), pursuant to the Business Combination Agreement, dated September 25, 2022 (the “Business Combination Agreement”), among the Company, GXII and Big Red Merger Sub Ltd (the “Closing”). At the Closing, the Company also closed convertible debt financings (the “Yorkville Convertible Debt Financing”) with YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (together with YA II PN, Ltd., “Yorkville”), and the standby equity purchase facility with Yorkville (the “Yorkville Equity Facility Financing” and, together with the Yorkville Convertible Debt Financing, the “Yorkville Financings”) became effective. The transactions contemplated by the Business Combination Agreement, including the GXII Transaction, the Yorkville Financings and the Reverse Stock Split (as defined below), are referred to, collectively, as the “Transactions.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The GXII Transaction is being accounted for as an equity raise transaction in accordance with generally accepted accounting principles of the United States of America (“U.S. GAAP”). Under this method of accounting, GXII is treated as the “acquired” company for financial reporting purposes. Accordingly, the GXII Transaction is treated as the equivalent of NioCorp issuing common shares, no par value, of the Company (“Common Shares”) for the assets and liabilities of GXII. The net assets of GXII are stated at historical cost, with no goodwill or other intangible assets recorded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These interim condensed consolidated financial statements have been prepared on a going concern basis that contemplates the realization of assets and discharge of liabilities at their carrying values in the normal course of business for the foreseeable future. These financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to construction and commercial operation. As further discussed in Note 4, these matters raised substantial doubt about the Company’s ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining additional financing and maintaining continued support from its shareholders and creditors.</span></p>
	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_809_eus-gaap--BasisOfAccounting_zLpGvdkPPZ0c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_829_zpzQCGF86Jni">BASIS OF PREPARATION</span></span></td> </tr></table> <p id="xdx_843_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zAXwDZdnv6B6" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zdyclvHIiN7l">Basis of Preparation and Consolidation</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. GAAP and the rules and regulations of the Securities and Exchange Commission (“SEC”). The interim condensed consolidated financial statements include the consolidated accounts of the Company and its wholly owned subsidiaries with all significant intercompany transactions eliminated. The accounting policies followed in preparing these interim condensed consolidated financial statements are those used by the Company as set out in the audited consolidated financial statements for the year ended June 30, 2022. Certain transactions include reference to Canadian dollars (“C$”) where applicable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the opinion of management, all adjustments considered necessary (including normal recurring adjustments) for a fair statement of the financial position, results of operations, and cash flows at March 31, 2023, and for all periods presented, have been included in these interim condensed consolidated financial statements. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to appropriate SEC rules and regulations. These interim condensed consolidated financial statements should</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">be read in conjunction with the audited consolidated financial statements for the year ended June 30, 2022. The interim results are not necessarily indicative of results for the full year ending June 30, 2023, or future operating periods.</span></p> <p id="xdx_856_z1IJGNuhpHw4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLiTDyOPfpE3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zwG1gLdKs4k9">Recent Accounting Standards</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued and Adopted</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”), which simplifies the accounting for convertible instruments. ASU 2020-06 removes certain accounting models which separate the embedded conversion features from the host contract for convertible instruments. Either a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company adopted ASU 2020-06 on July 1, 2022, with no material effect on the Company’ s current financial position, results of operations or financial statement disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued and Not Effective</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a material impact on the Company’s consolidated financial statements upon adoption.</span></p> <p id="xdx_85D_z06X5kq22j6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--UseOfEstimates_z5Hx4qiDhGB" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_ztXD8s4ZLHWh">Use of Estimates</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the deferred income tax asset valuations, convertible debt valuations, earnout valuation, warrant liabilities, and share-based compensation. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between estimates and the actual results, future results of operations will be affected.</p> <p id="xdx_85C_zAIz9Y9Tis1d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zNhRErpwvsb2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_zgZZpMBjmUSc">Basic and Diluted Earnings per Share</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Basic earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average number of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout Shares (each as defined in Note 9), to be participating securities, requiring the use of the two-class method. Diluted earnings per share represents net earnings attributable to common shareholders divided by the weighted average number of Common Shares outstanding, inclusive of the dilutive impact of all potentially dilutive securities outstanding during the period, as applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zAzEAmLJNQ6h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. <span id="xdx_8B2_zTx8XTrElIQ6">The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common shareholders for the three and nine months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 94%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="6" style="text-align: center">For the three months ended March 31,</td><td> </td><td> </td> <td colspan="6" style="text-align: center">For the nine months ended March 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Numerator:</td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 48%; text-align: justify; padding-left: 0.125in">Net loss</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ProfitLoss_iN_pn3n3_di_c20230101__20230331_zhAoUPzrmjZh" style="width: 10%; text-align: right" title="Net loss">29,435</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ProfitLoss_iN_pn3n3_di_c20220101__20220331_zs6I9NaoSKdb" style="width: 10%; text-align: right" title="Net loss">2,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ProfitLoss_iN_pn3n3_di_c20220701__20230331_zadAjMRsbkjf" style="width: 10%; text-align: right" title="Net loss">35,741</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$ </td><td id="xdx_986_eus-gaap--ProfitLoss_iN_pn3n3_di_c20210701__20220331_zHWcxSfgM552" style="width: 10%; text-align: right" title="Net loss">8,080</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Adjust: Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20230101__20230331_zG631EkpOZW3" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest">(56</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220101__20220331_znHAm4r142N6" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest"><span style="-sec-ix-hidden: xdx2ixbrl0705">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220701__20230331_zviSFSqMP3dj" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest">(43</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220331_z9glzhxGe39i" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.125in">Net loss available to participating securities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230101__20230331_zDGDv4sHJEnk" style="text-align: right" title="Net Loss available to participating securities">29,379</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220101__20220331_z93O5h49ezt4" style="text-align: right" title="Net Loss available to participating securities">2,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230331_ziP1cMq9o6s8" style="text-align: right" title="Net Loss available to participating securities">35,698</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20210701__20220331_zvWNhkWLG1Oj" style="text-align: right" title="Net Loss available to participating securities">8,080</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Net loss attributable to Vested Shares</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230101__20230331_zCjYzqhfNbrf" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares">(708</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220101__20220331_zdijG2VOEo43" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares"><span style="-sec-ix-hidden: xdx2ixbrl0721">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230331_z3q864WV9Dz9" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares">(271</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20210701__20220331_zg29RaysH4a2" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares"><span style="-sec-ix-hidden: xdx2ixbrl0725">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 0.125in">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230101__20230331_zWDFcDtHN322" style="border-bottom: Black 2.5pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted">28,671</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220101__20220331_zRKFO2Enq7ze" style="border-bottom: Black 2.5pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted">2,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230331_zTvkjRjMIPFf" style="border-bottom: Black 2.5pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted">35,427</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20210701__20220331_zTMsVJpQJl6d" style="border-bottom: Black 2.5pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted">8,080</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.125in">Weighted average shares outstanding – basic and diluted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230101__20230331_zj1OeOSHp4We" style="text-align: right" title="Weighted average shares outstanding basic and diluted">28,546,379</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220101__20220331_zkGwE06sbxuc" style="text-align: right" title="Weighted average shares outstanding basic and diluted">26,576,440</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230331_z3cQVR5m3Stb" style="text-align: right" title="Weighted average shares outstanding basic and diluted">28,128,731</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20210701__20220331_zLCdDn8swYfc" style="text-align: right" title="Weighted average shares outstanding basic and diluted">26,172,981</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.125in">Loss per Common Share outstanding – basic and diluted</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331_zVI72NE8MCvh" style="text-align: right" title="Loss per Common Share outstanding basic and diluted">1.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220101__20220331_zFTNNj2wj8u4" style="text-align: right" title="Loss per Common Share outstanding basic and diluted">0.08</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331_zW537VHqISyh" style="text-align: right" title="Loss per Common Share outstanding basic and diluted">1.26</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20210701__20220331_zzo9USjX6eIk" style="text-align: right" title="Loss per Common Share outstanding basic and diluted">0.31</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A7_zzIBdR3ZVN67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following shares underlying Options, Warrants, outstanding convertible debt and redeemable noncontrolling interest shares were antidilutive due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the three- and nine-month periods ended March 31, 2023 and 2022, as indicated below.</p> <p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"/> <p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zUrvV9Y0Eqa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span id="xdx_8BE_z7fATK5Hvzsl" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td> </td> <td colspan="6" style="text-align: center">For the three and nine months ended <br/>March 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Excluded potentially dilutive securities <sup id="xdx_F47_z3sfep8AFuS6">(1)(2)</sup>:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 62%">Options</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230331_fKDEp_zhsD3nNXGMFe" style="width: 11%; text-align: right" title="Options">1,561,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20210701__20220331_fKDEp_zD0KjX9RTP9k" style="width: 11%; text-align: right">1,408,900</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230331_fKDEp_z3H2q9ozem7a" style="text-align: right" title="Warrants">19,257,515</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20210701__20220331_fKDEp_zp13gNZduJ9j" style="text-align: right">1,347,011</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Convertible debt</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt"> </td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230331_fKDEp_z5sCQspQmh71" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,723,500</td><td style="text-align: left; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt"> </td><td id="xdx_983_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20210701__20220331_fKDEp_zSZmi5HxjqYf" style="border-bottom: Black 1pt solid; text-align: right">632,900</td><td style="text-align: left; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total potential dilutive securities</td><td> </td> <td style="border-bottom: Black 2pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_uShares_c20220701__20230331_fKDEp_zKO7j9OeMQs9" style="border-bottom: Black 2pt solid; text-align: right" title="Total potential dilutive securities">23,542,515</td><td style="text-align: left"> </td><td> </td> <td style="border-bottom: Black 2pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_uShares_c20210701__20220331_fKDEp_zHJIq8iIiJR6" style="border-bottom: Black 2pt solid; text-align: right">3,388,811</td><td style="text-align: left"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<i id="xdx_F0F_zblQYyWSQG42">1</i>)</span></td> <td style="padding-bottom: 4pt; text-align: justify">The number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as of the period end. Such amounts have <i>not</i> been adjusted for the treasury stock method or weighted average outstanding calculations as required if the securities were dilutive.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="font-size: 10pt; width: 0.5in"> </td> <td style="font-size: 10pt; text-align: justify; width: 0.5in"><span style="font-size: 10pt">(2)</span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Earnout Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period. </span></td></tr> </table> <p id="xdx_8A2_zGP4jBOVqlg1" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_85E_zRengp1SSh4" style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_847_ecustom--ReverseStockSplitPolicyTextBlock_zTfjmZ5euLd9" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_867_zqe6bos6Wxq9">Reverse Stock Split</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 17, 2023, the Company effected a reverse stock split (the “Reverse Stock Split”) on the basis of one (1) post-Reverse Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and outstanding, with any fractional shares resulting from the Reverse Stock Split rounded down to the nearest whole share. Immediately after the Reverse Stock Split, there were <span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_uShares_c20230317_z85qjUWeQfCg" title="Reverse stock split common shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_uShares_c20230317_zb7sTo2Yusce" title="Reverse stock split common shares outstanding">30,000,442</span></span> Common Shares issued and outstanding. All references to share and per share amounts (excluding authorized shares) in the consolidated financial statements and accompanying notes have been retroactively restated to reflect the Reverse Stock Split.</span></p> <p id="xdx_858_zgGqvlLumJqb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p id="xdx_842_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_z2QobtzZW7Y5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_zK1oET6DFIrh">Redeemable Noncontrolling Interest</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence of an event that is not solely within the Company’s control and is reported in the mezzanine section between total liabilities and shareholders’ deficit, as temporary equity in the Company’s consolidated balance sheets. The Company adjusts the Redeemable Noncontrolling Interest balance to reflect its estimate of the maximum redemption amount each reporting period. The Company’s non-controlling interest is redeemable at fair value, and no adjustment to the earnings per share numerator is required because redemption at fair value is not considered an economic distribution different from other common stockholders.</span></p> <p id="xdx_854_zVPoQePIMP61" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--ForeignCurrencyTranslationAndFunctionalCurrencyConversionPolicyTextBlock_z0zpNyl3PHwa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zRSr2pepUrwc">Foreign Currency Translation and Functional Currency Conversion</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items included in these interim condensed consolidated financial statements of each of the Company and the Company’s consolidated subsidiaries are measured using the currency of the primary economic environment in which the entities operate (the “functional currency”). Prior to March 17, 2023, the Company’s functional currency was the Canadian dollar. Translation gains and losses from the application of the U.S. dollar as the reporting currency during the period that the Canadian dollar was the functional currency are included as part of cumulative currency translation adjustment, which is reported as a component of shareholders’ equity under accumulated other comprehensive loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company re-assessed its functional currency and determined that on March 17, 2023, its functional currency changed from the Canadian dollar to the U.S. dollar based on significant changes in economic facts and circumstances in our organization. The change in functional currency was accounted for prospectively from March 17, 2023 and prior-period financial statements were not restated for the change in functional currency.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For both monetary and non-monetary assets and liabilities, translated balances as of March 17, 2023 became the new accounting basis. The exchange rate on the date of change became the historical rate at which non-monetary assets and liabilities were translated in subsequent periods. There was no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded cumulative translation adjustments were not reversed. For periods commencing after March 17, 2023, monetary assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates in effect at the balance sheet date. Opening balances related to non-monetary assets and liabilities are based on prior period translated amounts, and non-monetary assets and non-monetary liabilities incurred after March 17, 2023 are translated at the approximate exchange rate prevailing at the date of the transaction. Revenue and expense transactions are translated at the approximate exchange rate in effect at the time of the transactions. Foreign exchange gains and losses are included in the statement of operations and comprehensive loss as foreign exchange gains.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional currency for the Company’s Canadian subsidiary, 0896800 BC Ltd., which has no independent operations from its parent, also changed from the Canadian dollar to the U.S. dollar. The functional currency for Elk Creek Resources Corp. remains as the U.S. dollar.</span></p> <p id="xdx_85A_zICCqTFKiIul" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_z5Hx4qiDhGB" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_ztXD8s4ZLHWh">Use of Estimates</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the deferred income tax asset valuations, convertible debt valuations, earnout valuation, warrant liabilities, and share-based compensation. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between estimates and the actual results, future results of operations will be affected.</p>
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-29435000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2000000	usd
	us-gaap	Profit Loss ProfitLoss	-35741000	usd
	us-gaap	Profit Loss ProfitLoss	-8080000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-56000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-43000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	29379000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	35698000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8080000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-708000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-271000	usd
CY2023Q1	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	28671000	usd
CY2022Q1	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	2000000	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	35427000	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	8080000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28546379	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26576440	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28128731	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26172981	shares
CY2023Q1	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	1.00
CY2022Q1	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.08
	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	1.26
	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.31
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	1561500	shares
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	1408900	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	19257515	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1347011	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	2723500	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	632900	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	23542515	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3388811	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30000442	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30000442	shares
	niobf	Foreign Currency Transaction Gain Loss Before Tax1 ForeignCurrencyTransactionGainLossBeforeTax1	-200000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1305000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	8432000	usd
	niobf	Minimum Consent Payment At Inception MinimumConsentPaymentAtInception	200000	usd
	niobf	Debt Extinguishment Fair Value Adjustment DebtExtinguishmentFairValueAdjustment	201000	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	1221000	usd
	niobf	Gains Losses On Extinguishment Of Debt1 GainsLossesOnExtinguishmentOfDebt1	1622000	usd
CY2022Q3	us-gaap	Deferred Costs DeferredCosts	2609000	usd
CY2022Q3	us-gaap	Assets Assets	23046000	usd
CY2022Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	914000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6670000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	964000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	7634000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-114274000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	15412000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23046000	usd
CY2022Q3	niobf	Interest Expense1 InterestExpense1	258000	usd
CY2022Q3	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	1622000	usd
CY2022Q3	niobf	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	257000	usd
CY2022Q3	niobf	Net Loss NetLoss	3877000	usd
CY2022Q3	niobf	Comprehensive Income Net Of Tax1 ComprehensiveIncomeNetOfTax1	3882000	usd
CY2022Q3	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.14
CY2022Q3	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	27792632	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3877000	usd
CY2022Q3	us-gaap	Accretion Expense AccretionExpense	194000	usd
CY2022Q3	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	1622000	usd
CY2022Q3	niobf	Change In Financial Instrument Fair Value ChangeInFinancialInstrumentFairValue	-257000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17665000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	1650000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	21000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5000	usd
CY2022Q3	niobf	Net Income Loss Two NetIncomeLossTwo	-3877000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	15412000	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	4138000	usd
CY2022Q4	us-gaap	Assets Assets	21701000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	541000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7127000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116703000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13269000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21701000	usd
CY2022Q4	niobf	Interest Expense1 InterestExpense1	-38000	usd
CY2022Q4	niobf	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-341000	usd
CY2022Q4	niobf	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest1 IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1	2429000	usd
CY2022Q4	niobf	Net Loss NetLoss	2429000	usd
CY2022Q4	niobf	Comprehensive Income Net Of Tax1 ComprehensiveIncomeNetOfTax1	-2454000	usd
CY2022Q4	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.09
CY2022Q4	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	28056263	shares
	niobf	Interest Expense1 InterestExpense1	220000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1622000	usd
	niobf	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-84000	usd
	niobf	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest1 IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1	6306000	usd
	niobf	Net Loss NetLoss	6306000	usd
	niobf	Comprehensive Income Net Of Tax1 ComprehensiveIncomeNetOfTax1	-6336000	usd
	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.23
	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	27924227	shares
	us-gaap	Net Income Loss NetIncomeLoss	-6306000	usd
	us-gaap	Accretion Expense AccretionExpense	121000	usd
	niobf	Losses On Extinguishment Of Debt LossesOnExtinguishmentOfDebt	1622000	usd
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	84000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	15412000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	300000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-25000	usd
CY2022Q4	niobf	Net Income Loss Three NetIncomeLossThree	-2429000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13269000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17665000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	1950000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-21000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-30000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6306000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13269000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-66000	usd
CY2022Q1	niobf	Interest Expense1 InterestExpense1	679000	usd
CY2022Q1	niobf	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest1 IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1	2000000	usd
CY2022Q1	niobf	Net Loss NetLoss	2000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	38000	usd
CY2022Q1	niobf	Comprehensive Income Net Of Tax1 ComprehensiveIncomeNetOfTax1	2038000	usd
CY2022Q1	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.08
CY2022Q1	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	26576440	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	14296000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2000000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	14368000	usd
	niobf	Foreign Currency Transaction Gain Loss Before Tax Operation ForeignCurrencyTransactionGainLossBeforeTaxOperation	98000	usd
	niobf	Interest Expense1 InterestExpense1	2306000	usd
	niobf	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest1 IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1	8080000	usd
	niobf	Comprehensive Income Net Of Tax1 ComprehensiveIncomeNetOfTax1	8008000	usd
	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.31
	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	26172981	shares
	us-gaap	Net Income Loss NetIncomeLoss	-8080000	usd
	us-gaap	Accretion Expense AccretionExpense	2149000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13213000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8080000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	72000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	14368000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-35649000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-146046000	usd
	niobf	Cash And Cash Equivalents At Carrying Value1 CashAndCashEquivalentsAtCarryingValue1	7145000	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	61600000	usd
CY2023Q1	niobf	Transaction Costs TransactionCosts	15676	usd
CY2023Q1	us-gaap	Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Costs BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts	2168000	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	392000	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Capital Lease Obligation BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation	3848000	usd
CY2023Q1	niobf	Earnout Shares Assumed At Fair Value EarnoutSharesAssumedAtFairValue	13195000	usd
CY2023Q1	us-gaap	Business Combination Separately Recognized Transactions Additional Disclosures Issuance Costs Not Expensed BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresIssuanceCostsNotExpensed	6309000	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Less Noncontrolling Interest BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest	21576000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	48000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	3319000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	817000	usd
CY2023Q1	us-gaap	Convertible Debt ConvertibleDebt	12263000	usd
CY2023Q1	us-gaap	Option Contract Indexed To Equity Settlement Number Of Shares Effect Of Change In Fair Value Of Share OptionContractIndexedToEquitySettlementNumberOfSharesEffectOfChangeInFairValueOfShare	42300	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	917000	usd
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1561500	shares
CY2023Q1	niobf	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue1	917000	usd
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30081655	shares
	us-gaap	Subsidiary Or Equity Method Investee Cumulative Percentage Ownership After All Transactions SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions	1	pure
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	926000	usd
CY2022Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	115000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2055000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	654000	usd
CY2023Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	259000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Fair Value Disclosure AccountsPayableAndAccruedLiabilitiesFairValueDisclosure	31000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	48000	usd
	niobf	Minimum Consent Payment At Inception MinimumConsentPaymentAtInception	200000	usd
	niobf	Asc470 Loss On Extinguishment ASC470LossOnExtinguishment	201000	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	1221000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1622000	usd
	niobf	Schedule Of Warrant Valuation Table Textblock ScheduleOfWarrantValuationTableTextblock	<p id="xdx_895_ecustom--ScheduleOfWarrantValuationTableTextblock_zdnymbIwTe1e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_z3KXdJqZzPm3">Changes in the fair value of the Contingent Consent Warrants are presented below:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: justify; text-indent: -8.65pt; padding-left: 8.65pt"> </td><td> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 37%; text-align: justify; text-indent: -8.65pt; padding-left: 8.65pt">Initial valuation, September 25, 2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iS_c20220923__20220930_z3zk9dNEIAJh" style="width: 10%; text-align: right" title="Initial valuation, at beginning">1,221</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 0.25in">Change in valuation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ChangeInValuationOfWarrants_c20220923__20220930_zxCQNHnwx7lj" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation">(257</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; text-indent: -8.65pt; padding-left: 8.65pt">Valuation at September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstanding_iS_c20221001__20221231_zwxEWPYvOjeh" style="text-align: right">964</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 0.25in">Change in valuation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_ecustom--ChangeInValuationOfWarrants_c20221001__20221231_z2yeJhZmuvT2" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation">341</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; text-indent: -8.65pt; padding-left: 8.65pt">Valuation at December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--WarrantsAndRightsOutstanding_iS_c20230101__20230331_zHmhUmSTtn3d" style="text-align: right">1,305</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 0.25in">Change in valuation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_ecustom--ChangeInValuationOfWarrants_c20230101__20230331_zWSyBMkXjsS8" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation">220</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2pt; text-indent: -8.65pt; padding-left: 8.65pt">Valuation at March 31, 2023</td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstanding_iE_c20230101__20230331_zpnY2639qHGk" style="border-bottom: Black 2pt solid; text-align: right" title="Initial valuation, at ending">1,525</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table>
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1221000	usd
CY2022Q3	niobf	Change In Valuation Of Warrants ChangeInValuationOfWarrants	-257000	usd
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	964000	usd
CY2022Q4	niobf	Change In Valuation Of Warrants ChangeInValuationOfWarrants	341000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1305000	usd
CY2023Q1	niobf	Change In Valuation Of Warrants ChangeInValuationOfWarrants	220000	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1525000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	15360000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	15360000	usd
CY2022Q2	us-gaap	Convertible Debt ConvertibleDebt	12153000	usd
	us-gaap	Accretion Expense Including Asset Retirement Obligations AccretionExpenseIncludingAssetRetirementObligations	110000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1446400	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.30
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	578000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.52
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	265129	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.99
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	197771	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.09
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1561500	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.69
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1561500	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1851622	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	8.99
	niobf	Class Of Warrant Or Right Granted ClassOfWarrantOrRightGranted	17455893	shares
	niobf	Class Of Warrant Or Right Exercise Price Granted ClassOfWarrantOrRightExercisePriceGranted	11.24
	niobf	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	-50000	shares
	niobf	Class Of Warrant Or Right Exercise Price Expired ClassOfWarrantOrRightExercisePriceExpired	5.91
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	19257515	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.99
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	19257515	shares
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	12000	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	6000	usd
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	8000	usd
	us-gaap	Sublease Income SubleaseIncome	24000	usd
	us-gaap	Sublease Income SubleaseIncome	23000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	15000	usd
CY2023Q1	niobf	Amount Paid To Related Party AmountPaidToRelatedParty	1130000	usd
CY2023Q1	us-gaap	Exploration Expense ExplorationExpense	1410000	usd
CY2022Q1	us-gaap	Exploration Expense ExplorationExpense	845000	usd
	us-gaap	Exploration Expense ExplorationExpense	4015000	usd
	us-gaap	Exploration Expense ExplorationExpense	1957000	usd
CY2023Q1	niobf	Fixed Rent Expense FixedRentExpense	15000	usd
CY2022Q1	niobf	Fixed Rent Expense FixedRentExpense	23000	usd
	niobf	Fixed Rent Expense FixedRentExpense	60000	usd
	niobf	Fixed Rent Expense FixedRentExpense	66000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	3000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	2000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	9000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	7000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	21000	usd
	us-gaap	Lease Cost LeaseCost	52000	usd
	us-gaap	Lease Cost LeaseCost	62000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	338000	usd
CY2023Q1	niobf	Less Amount Of Payments Representing Interest LessAmountOfPaymentsRepresentingInterest	91000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	247000	usd
CY2023Q1	niobf	Less Current Portion Of Lease Payments LessCurrentPortionOfLeasePayments	-70000	usd
CY2023Q1	niobf	Non Current Lease Liability NonCurrentLeaseLiability	177000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	7145000	usd
CY2023Q1	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	7000	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	7152000	usd
CY2023Q1	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	12314000	usd
CY2023Q1	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	5303000	usd
CY2023Q1	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	17617000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	5280000	usd
CY2022Q2	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	10000	usd
CY2022Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	5290000	usd

Files In Submission

Name	View Source	Status
0001539497-23-001028-index-headers.html	Edgar Link	pending
0001539497-23-001028-index.html	Edgar Link	pending
0001539497-23-001028.txt	Edgar Link	pending
0001539497-23-001028-xbrl.zip	Edgar Link	pending
exh31-1.htm	Edgar Link	pending
exh31-2.htm	Edgar Link	pending
exh32-1.htm	Edgar Link	pending
exh32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
n2574_x137-10q.htm	Edgar Link	pending
n2575_10q-img001.jpg	Edgar Link	pending
niobf-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
niobf-20230331_def.xml	Edgar Link	unprocessable
niobf-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
niobf-20230331_pre.xml	Edgar Link	unprocessable
n2574_x137-10q_htm.xml	Edgar Link	completed
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
niobf-20230331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NB
NIOCORP DEVELOPMENTS LTD Stock $nb

2023 Q2 Form 10-Q Financial Statement

#000153949723001028 Filed on May 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NB NIOCORP DEVELOPMENTS LTD Stock $nb

2023 Q2 Form 10-Q Financial Statement

#000153949723001028 Filed on May 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NB
NIOCORP DEVELOPMENTS LTD Stock $nb